Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
VESCALAGIN
ID: ALA607711
Max Phase: Preclinical
Molecular Formula: C41H26O26
Molecular Weight: 934.63
Molecule Type: Small molecule
Associated Items:
ID: ALA607711
Max Phase: Preclinical
Molecular Formula: C41H26O26
Molecular Weight: 934.63
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Vescalagin
Synonyms from Alternative Forms(1):
Canonical SMILES: O=C1OCC2OC(=O)c3cc(O)c(O)c(O)c3-c3c(O)c(O)c(O)c4c3C(=O)OC(C2OC(=O)c2cc(O)c(O)c(O)c2-c2c1cc(O)c(O)c2O)C1OC(=O)c2c-4c(O)c(O)c(O)c2C1O
Standard InChI: InChI=1S/C41H26O26/c42-8-1-5-12(24(48)21(8)45)13-6(2-9(43)22(46)25(13)49)39(60)65-34-11(4-63-37(5)58)64-38(59)7-3-10(44)23(47)26(50)14(7)15-18-16(28(52)32(56)27(15)51)17-19-20(30(54)33(57)29(17)53)31(55)35(66-41(19)62)36(34)67-40(18)61/h1-3,11,31,34-36,42-57H,4H2
Standard InChI Key: UDYKDZHZAKSYCO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 934.63 | Molecular Weight (Monoisotopic): 934.0712 | AlogP: 1.32 | #Rotatable Bonds: 0 |
Polar Surface Area: 455.18 | Molecular Species: NEUTRAL | HBA: 26 | HBD: 16 |
#RO5 Violations: 3 | HBA (Lipinski): 26 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 6.87 | CX Basic pKa: | CX LogP: 2.03 | CX LogD: 1.03 |
Aromatic Rings: 5 | Heavy Atoms: 67 | QED Weighted: 0.06 | Np Likeness Score: 0.99 |
1. König M, Scholz E, Hartmann R, Lehmann W, Rimpler H.. (1994) Ellagitannins and complex tannins from Quercus petraea bark., 57 (10): [PMID:7807126] [10.1021/np50112a010] |
2. Adamczeski M, Ni JX, Jaber H, Huang J, Kang R, Nakatsu T. (1992) A Novel Hydrolyzable Tannin and Related Compounds Isolated from the Leaf Surface of Chrysolepis sempervirens, 55 (4): [10.1021/np50082a024] |
3. Kashiwada Y, Nonaka G, Nishioka I, Chang JJ, Lee KH.. (1992) Antitumor agents, 129. Tannins and related compounds as selective cytotoxic agents., 55 (8): [PMID:1431932] [10.1021/np50086a002] |
4. Haslam E.. (1996) Natural polyphenols (vegetable tannins) as drugs: possible modes of action., 59 (2): [PMID:8991956] [10.1021/np960040+] |
Source(1):